Detalhe da pesquisa
1.
Empagliflozin in Patients with Chronic Kidney Disease.
N Engl J Med
; 388(2): 117-127, 2023 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331190
2.
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
Circulation
; 149(23): 1789-1801, 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38583093
3.
SGLT2 Inhibitors: The Sweet Success for Kidneys.
Annu Rev Med
; 74: 369-384, 2023 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706745
4.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Lancet
; 403(10424): 379-390, 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38109916
5.
Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials.
J Am Soc Nephrol
; 2024 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38795055
6.
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD.
J Am Soc Nephrol
; 35(2): 202-215, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38082486
7.
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes.
Diabetologia
; 67(1): 3-18, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801140
8.
Evaluation of glomerular hemodynamic changes by sodium-glucose-transporter 2 inhibition in type 2 diabetic rats using in vivo imaging.
Kidney Int
; 2024 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38801992
9.
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
N Engl J Med
; 384(2): 129-139, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200891
10.
Virtual Pharmacy: An Integrated Collaborative Redesign Targeting Medication-Related Problems in Patients with Chronic Kidney Disease.
Am J Nephrol
; 55(2): 206-213, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37939689
11.
Proximal versus distal diuretics in congestive heart failure.
Nephrol Dial Transplant
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38425090
12.
Volenrelaxin (LY3540378) increases Renal Plasma Flow: A Randomized Phase 1 Trial.
Nephrol Dial Transplant
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782726
13.
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.
Nephrol Dial Transplant
; 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38858818
14.
An update review of post-transplant diabetes mellitus: Concept, risk factors, clinical implications and management.
Diabetes Obes Metab
; 26(7): 2531-2545, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38558257
15.
Inter-relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management.
Diabetes Obes Metab
; 26(5): 1567-1581, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328853
16.
Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition.
Circulation
; 146(6): 450-462, 2022 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35862082
17.
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials.
Circulation
; 145(19): 1460-1470, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35394821
18.
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo.
Kidney Int
; 103(4): 772-781, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36738891
19.
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
N Engl J Med
; 383(15): 1425-1435, 2020 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32966714
20.
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.
N Engl J Med
; 382(26): 2493-2503, 2020 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32579810